Ionis Pharmaceuticals, Inc. (IONS)
43.54
-0.46
(-1.05%)
USD |
NASDAQ |
Oct 02, 16:00
43.60
+0.06
(+0.14%)
After-Hours: 20:00
Ionis Pharmaceuticals Market Cap : 7.212B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 7.212B |
| October 01, 2026 | 7.288B |
| September 30, 2026 | 7.396B |
| September 29, 2026 | 7.601B |
| September 28, 2026 | 7.548B |
| September 25, 2026 | 7.371B |
| September 24, 2026 | 7.257B |
| September 23, 2026 | 7.276B |
| September 22, 2026 | 7.578B |
| September 21, 2026 | 7.437B |
| September 18, 2026 | 7.361B |
| September 17, 2026 | 7.744B |
| September 16, 2026 | 7.427B |
| September 15, 2026 | 7.826B |
| September 14, 2026 | 8.520B |
| September 11, 2026 | 8.979B |
| September 10, 2026 | 9.218B |
| September 09, 2026 | 9.279B |
| September 08, 2026 | 9.393B |
| September 04, 2026 | 9.622B |
| September 03, 2026 | 9.628B |
| September 02, 2026 | 10.16B |
| September 01, 2026 | 9.918B |
| August 31, 2026 | 9.998B |
| August 28, 2026 | 10.11B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.34B |
| August 26, 2026 | 10.49B |
| August 25, 2026 | 10.53B |
| August 24, 2026 | 10.28B |
| August 21, 2026 | 9.895B |
| August 20, 2026 | 9.733B |
| August 19, 2026 | 10.07B |
| August 18, 2026 | 9.875B |
| August 17, 2026 | 9.711B |
| August 14, 2026 | 9.481B |
| August 13, 2026 | 9.254B |
| August 12, 2026 | 9.363B |
| August 11, 2026 | 9.180B |
| August 10, 2026 | 9.431B |
| August 07, 2026 | 9.368B |
| August 06, 2026 | 9.026B |
| August 05, 2026 | 8.976B |
| August 04, 2026 | 9.122B |
| August 03, 2026 | 9.026B |
| July 31, 2026 | 8.575B |
| July 30, 2026 | 8.825B |
| July 29, 2026 | 8.951B |
| July 28, 2026 | 9.160B |
| July 27, 2026 | 9.269B |
| July 24, 2026 | 9.382B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Biogen, Inc. | 32.48B |
| BridgeBio Pharma, Inc. | 13.13B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| Pfizer Inc. | 158.43B |
Market Cap Related Metrics
| PS Ratio | 8.123 |
| PEG Ratio | -0.1432 |
| Price to Book Value | 16.40 |
| Price | 43.54 |
| Earnings Yield | -7.98% |
| PEGY Ratio | -0.1432 |